TEVA PHARMACEUTICALS USA, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 22140
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 18237
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 14124
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 590
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 2445
 
  
 
H04L TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 2283
 
  
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 1108
 
  
 
B05D PROCESSES FOR APPLYING LIQUIDS OR OTHER FLUENT MATERIALS TO SURFACES, IN GENERAL 186
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 169

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9231824 Configuration synchronization between electronic gaming machines and a supporting serverDec 18, 07Jan 05, 16[H04L, G06F, G07F]
9085507 Desfesoterodine in the form of a tartaric acid saltMay 10, 10Jul 21, 15[A61K, C07C]
8889213 Processes for coating a carrier with microparticlesJan 26, 10Nov 18, 14[A61K, B05D, B01J]
8865722 Wet formulations of aripiprazoleMar 14, 06Oct 21, 14[A61K]
8809310 Use of rasagiline for the treatment of multiple system atrophyFeb 21, 07Aug 19, 14[A01N]
8802854 Crystalline forms of Prasugrel saltsApr 07, 11Aug 12, 14[A61K, C07D]
8766005 Process for producing fingolimod saltsJul 23, 10Jul 01, 14[A61K, C07C]
8742129 Crystalline forms of febuxostatMar 01, 13Jun 03, 14[C07D]
8618309 Sunitinib and salts thereof and their polymorphsJul 23, 09Dec 31, 13[C07D]
8609856 Crystalline forms of FebuxostatMar 01, 13Dec 17, 13[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0324,943 PROCESS FOR PRODUCTION OF BIVALIRUDINAbandonedAug 26, 15Nov 10, 16[A61K]
2016/0193,276 TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATEAbandonedDec 20, 13Jul 07, 16[A61K]
2016/0038,435 TRANSDERMAL FORMULATIONS OF LAQUINIMODAbandonedMar 13, 14Feb 11, 16[A61K]
2015/0328,277 ORAL TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATEAbandonedDec 20, 13Nov 19, 15[A61K]
2015/0216,850 COMBINATION OF RASAGILINE AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASEAbandonedSep 27, 13Aug 06, 15[A61K]
2015/0209,346 COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASEAbandonedSep 27, 13Jul 30, 15[A61K, B65D]
2014/0050,784 PHARMACEUTICAL COMPOSITIONS OF MEMANTINEAbandonedAug 16, 13Feb 20, 14[A61K]
2013/0203,674 PROCESS FOR PRODUCTION OF BIVALIRUDINAbandonedMar 25, 13Aug 08, 13[A61K, C07K]
2013/0196,916 PROCESS FOR PRODUCTION OF BIVALIRUDINAbandonedMar 25, 13Aug 01, 13[A61K, C07K]
2013/0196,917 PROCESS FOR PRODUCTION OF BIVALIRUDINAbandonedMar 25, 13Aug 01, 13[A61K]
2013/0196,918 PROCESS FOR PRODUCTION OF BIVALIRUDINAbandonedMar 25, 13Aug 01, 13[A61K]
2013/0196,919 PROCESS FOR PRODUCTION OF BIVALIRUDINAbandonedMar 25, 13Aug 01, 13[A61K, C07K]
2013/0196,920 PROCESS FOR PRODUCTION OF BIVALIRUDINAbandonedMar 25, 13Aug 01, 13[A61K, C07K]
2013/0065,888 OPHTHALMIC FORMULATIONS AND PROCESSES FOR THEIR PREPARATIONAbandonedAug 14, 12Mar 14, 13[A61K, A61P]
2012/0301,541 COMPRESSED CORE FOR PHARMACEUTICAL COMPOSITIONAbandonedMay 24, 12Nov 29, 12[A61J, A61K, B05D]
2012/0220,663 SOLID FORMS OF ALISKIREN HEMIFUMARATE AND PROCESSES FOR PREPARATION THEREOFAbandonedSep 02, 10Aug 30, 12[A61K, C07C, A61P]
8252805 Forms of lapatinib ditosylate and processes for preparation thereofExpiredMay 07, 09Aug 28, 12[A61K, A01N, C07D]
2012/0195,933 PHARMACEUTICAL COMPOSITIONS COMPRISING TASOCITINIBAbandonedJan 27, 12Aug 02, 12[A61K, A61P]
2012/0195,966 ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITORAbandonedJan 27, 12Aug 02, 12[A61J, A61K, B05D]
8226977 Pharmaceutical composition containing irbesartanExpiredJun 02, 05Jul 24, 12[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.